Intervacc is trading 18.27% down at €0.06 after falling from recent €0.07 closes; the cause remains unclear.
- No credible company-specific announcement, earnings update, regulatory action, transaction or analyst catalyst was identified for September 22–23, 2026.
- The latest identified company news was a September 15 conference-presentation announcement, not a new catalyst.
- Broader biotech strength does not explain the opposite-direction move.